BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19744519)

  • 21. Clinical and molecular characteristics of bloodstream infections caused by Candida albicans in children from 2003 to 2011.
    Tsai MH; Wang SH; Hsu JF; Lin LC; Chu SM; Huang HR; Chiang MC; Fu RH; Lu JJ; Huang YC
    Clin Microbiol Infect; 2015 Nov; 21(11):1018.e1-8. PubMed ID: 26148466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candidaemia in a large teaching hospital: a clinical audit.
    Aliyu SH; Enoch DA; Abubakar II; Ali R; Carmichael AJ; Farrington M; Lever AM
    QJM; 2006 Oct; 99(10):655-63. PubMed ID: 16935923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology and management of candidaemia--a retrospective, multicentre study in five hospitals in the UK.
    Chalmers C; Gaur S; Chew J; Wright T; Kumar A; Mathur S; Wan WY; Gould IM; Leanord A; Bal AM
    Mycoses; 2011 Nov; 54(6):e795-800. PubMed ID: 21615542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study.
    Garey KW; Turpin RS; Bearden DT; Pai MP; Suda KJ
    Int J Antimicrob Agents; 2007 May; 29(5):557-62. PubMed ID: 17341444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital.
    Yapar N; Uysal U; Yucesoy M; Cakir N; Yuce A
    Mycoses; 2006 Mar; 49(2):134-8. PubMed ID: 16466448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal candidaemia in Kuwait: a 12-year study of risk factors, species spectrum and antifungal susceptibility.
    Al-Sweih N; Khan Z; Khan S; Devarajan LV
    Mycoses; 2009 Nov; 52(6):518-23. PubMed ID: 18983425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candidaemia in patients of a tertiary health care hospital from north India.
    Verma AK; Prasad KN; Singh M; Dixit AK; Ayyagari A
    Indian J Med Res; 2003 Mar; 117():122-8. PubMed ID: 14575178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies.
    Falagas ME; Apostolou KE; Pappas VD
    Eur J Clin Microbiol Infect Dis; 2006 Jul; 25(7):419-25. PubMed ID: 16773391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nosocomial infections in the medical ICU: a retrospective study highlighting their prevalence, microbiological profile and impact on ICU stay and mortality.
    Pradhan NP; Bhat SM; Ghadage DP
    J Assoc Physicians India; 2014 Oct; 62(10):18-21. PubMed ID: 25906516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The predictors of outcome in immunocompetent patients with hematogenous candidiasis.
    Safdar A; Bannister TW; Safdar Z
    Int J Infect Dis; 2004 May; 8(3):180-6. PubMed ID: 15109594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: epidemiology and antifungal susceptibility.
    Dizbay M; Fidan I; Kalkanci A; Sari N; Yalcin B; Kustimur S; Arman D
    Scand J Infect Dis; 2010; 42(2):114-20. PubMed ID: 19883150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital.
    Luzzati R; Allegranzi B; Antozzi L; Masala L; Pegoraro E; Azzini A; Concia E
    Clin Microbiol Infect; 2005 Nov; 11(11):908-13. PubMed ID: 16216107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Observational study on candidaemia at a university hospital in southern Italy from 1998 to 2004.
    Caggiano G; Iatta R; Laneve A; Manca F; Montagna MT
    Mycoses; 2008 Mar; 51(2):123-8. PubMed ID: 18254748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal trends, risk factors and outcomes in albicans and non-albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units.
    Holley A; Dulhunty J; Blot S; Lipman J; Lobo S; Dancer C; Rello J; Dimopoulos G
    Int J Antimicrob Agents; 2009 Jun; 33(6):554.e1-7. PubMed ID: 19167196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving survival of patients with candidaemia: analysis of prognostic factors from a long-term, nationwide study in Iceland.
    Asmundsdóttir LR; Erlendsdóttir H; Gottfredsson M
    Scand J Infect Dis; 2005; 37(2):111-20. PubMed ID: 15764202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of risk factors and outcome among outpatient-acquired and nosocomial candidaemia.
    Pasqualotto AC; Nedel WL; Machado TS; Severo LC
    J Hosp Infect; 2005 Jun; 60(2):129-34. PubMed ID: 15866011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.
    Yamamura DL; Rotstein C; Nicolle LE; Ioannou S
    CMAJ; 1999 Feb; 160(4):493-9. PubMed ID: 10081465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candidaemia and cancer: patients are not all the same.
    Pasqualotto AC; Rosa DD; Medeiros LR; Severo LC
    BMC Infect Dis; 2006 Mar; 6():50. PubMed ID: 16542444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
    Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
    Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for candidaemia and their cumulative effect over time in a cohort of critically ill, non-neutropenic patients.
    Aljeboori Z; Gorelik A; Jenkins E; McFarlane T; Darvall J
    Crit Care Resusc; 2018 Dec; 20(4):313-319. PubMed ID: 30482139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.